Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium

 

• Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates
• New concordance analysis supporting the generation of Oncotype DX® results from core needle biopsy to personalize treatment decisions
• ADAPTcycle trial data, using Oncotype DX results and endocrine response to stratify patients, may expand the number of breast cancer patients able to forgo chemotherapy post-surgery; data chosen as late-breaking abstract
• Prospective trial data regarding the potential omission of radiation therapy after surgery in certain patients with ductal carcinoma in situ (DCIS) chosen for press program

https://www.prnewswire.com/news-releases/exact-sciences-presents-multiple-studies-at-san-antonio-breast-cancer-symposium-supporting-optimization-and-individualization-of-therapy-for-breast-cancer-patients-302002560.html